Home » Topics » BioWorld Science

BioWorld Science
RSS

Lipocine receives FDA complete response letter for Tlando

May 10, 2018

Provention Bio acquires rights to teplizumab and MGD-010 from MacroGenics

May 10, 2018

IGEM Therapeutics awarded grant from Innovate UK

May 10, 2018

AcelRx Pharmaceuticals resubmits Dsuvia NDA in U.S.

May 10, 2018

Novel Ironwood soluble guanylate cyclase stimulator reduces neuroinflammation

May 10, 2018

Development of Wayshine Biopharm compounds advances for brain and lung cancer

May 10, 2018

Pfizer reports regulatory and pipeline highlights of first quarter 2018

May 10, 2018

First subjects dosed in first-in-human study of TransCon CNP

May 10, 2018

Japan AMED selects FunPep project for orphan drug support program

May 10, 2018

BDII-selective inhibitor ABBV-744 active against acute myelogenous leukemia, prostate cancer

May 9, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.